BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $1.36 and traded as low as $1.10. BioRestorative Therapies shares last traded at $1.11, with a volume of 10,660 shares changing hands.
BioRestorative Therapies Stock Performance
The firm has a market cap of $9.85 million, a P/E ratio of -0.76 and a beta of 0.18. The company has a 50 day moving average of $1.36 and a 200 day moving average of $1.52.
About BioRestorative Therapies
BioRestorative Therapies, Inc engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company’s initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process.
See Also
- Five stocks we like better than BioRestorative Therapies
- How to Short Nasdaq: An Easy-to-Follow Guide
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- Energy and Oil Stocks Explained
- The Best Holiday Present You Can Give Yourself? Costco Stock
- What is the Dow Jones Industrial Average (DJIA)?
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
